Hot Pursuit     01-Dec-23
Biocon Ltd up for third consecutive session
Biocon Ltd is quoting at Rs 241.25, up 1.24% on the day as on 12:49 IST on the NSE. The stock is down 14.92% in last one year as compared to a 8.45% jump in NIFTY and a 24.4% jump in the Nifty Pharma index.

Biocon Ltd is up for a third straight session today. The stock is quoting at Rs 241.25, up 1.24% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.71% on the day, quoting at 20276.75. The Sensex is at 67486.34, up 0.74%. Biocon Ltd has gained around 8.79% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has gained around 9.75% in last one month and is currently quoting at 16238.9, up 0.25% on the day. The volume in the stock stood at 22.54 lakh shares today, compared to the daily average of 30.68 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 242.6, up 1% on the day. Biocon Ltd is down 14.92% in last one year as compared to a 8.45% jump in NIFTY and a 24.4% jump in the Nifty Pharma index.

The PE of the stock is 476.9 based on TTM earnings ending September 23.

Previous News
  Biocon gains as arm takes over Viatris' biosimilar biz in over 70 countries
 ( Hot Pursuit - 06-Jul-23   12:03 )
  Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
 ( Corporate News - 24-Jun-24   09:01 )
  Biocon arm completes integration of Viatris biosimilars biz
 ( Hot Pursuit - 07-Sep-23   09:45 )
  Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
 ( Hot Pursuit - 24-Jun-24   09:34 )
  Biocon Ltd soars 1.22%, rises for fifth straight session
 ( Hot Pursuit - 27-Mar-24   13:00 )
  Biocon signs exclusive licensing and supply agreement with Handok
 ( Corporate News - 24-May-24   09:06 )
  Biocon Ltd up for five straight sessions
 ( Hot Pursuit - 19-Feb-24   13:00 )
  Biocon appoints director
 ( Corporate News - 12-Dec-22   19:04 )
  Biocon Biologics completes integration of Viatris' biosimilars biz in over 70 countries
 ( Corporate News - 05-Jul-23   18:38 )
  Biocon update on subsidiary's biologics license application for Insulin-R product
 ( Corporate News - 07-Jan-23   12:33 )
  Biocon Ltd Slips 3.3%
 ( Hot Pursuit - 02-Jun-23   09:45 )
Other Stories
  Wipro Q1 PAT rises 6% QoQ to Rs 3,003 cr
  19-Jul-24   17:22
  BPCL tanks after Q1 PAT slides 71% YoY to Rs 3,015 cr in FY25
  19-Jul-24   15:45
  Fedbank Financial Services Q1 PAT rises 4% YoY to Rs 70 cr
  19-Jul-24   15:33
  UltraTech Cement Q1 PAT rises YoY to Rs 1,697 crore
  19-Jul-24   15:32
  Jubilant Pharmova hits 52-week high after Q1 PAT zooms to Rs 482 cr
  19-Jul-24   15:06
  Chennai Petroleum Corporation Ltd leads losers in 'A' group
  19-Jul-24   15:00
  Nakoda Group of Industries Ltd Partly Paidup leads losers in 'B' group
  19-Jul-24   14:45
  Volumes spurt at AIA Engineering Ltd counter
  19-Jul-24   14:30
  Metal stocks edge lower
  19-Jul-24   14:00
  Real Estate stocks edge lower
  19-Jul-24   14:00
Back Top